Receptor activator of nuclear factor kB ligand, osteoprotegerin, and risk of death following a breast cancer diagnosis: results from the EPIC cohort

Overview of attention for article published in BMC Cancer, October 2018

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (54th percentile)
Good Attention Score compared to outputs of the same age and source (73rd percentile)

Mentioned by

twitter: 6 X users

facebook: 2 Facebook pages

Citations

dimensions_citation: 10 Dimensions

Readers on

mendeley: 30 Mendeley

Summary X Facebook Dimensions citations

So far, Altmetric has seen 8 X posts from 6 X users, with an upper bound of 31,158 followers.

#PubSaludMurcia Receptor activator of nuclear factor kB ligand, osteoprotegerin, and risk of death following a breast cancer diagnosis: results from the EPIC cohort https://t.co/5KbsvxbnjF

31 Jan 2019

Reply Repost Favourite

New from #ERC_Research https://t.co/CmNTuhDZ3E Receptor activator of nuclear factor kB ligand, osteoprotegerin, and risk of death following a breast cancer diagnosis: results from the EPIC cohort

08 Nov 2018

Reply Repost Favourite

New from #CR_UK https://t.co/CmNTuhDZ3E Receptor activator of nuclear factor kB ligand, osteoprotegerin, and risk of death following a breast cancer diagnosis: results from the EPIC cohort

08 Nov 2018

Reply Repost Favourite

#PubSaludMurcia Receptor activator of nuclear factor kB ligand, osteoprotegerin, and risk of death following a breast cancer diagnosis: results from the EPIC cohort https://t.co/es4SwKpyHX

25 Oct 2018

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 4 additional X posts.